Prostate Cancer Drugs Aren’t Tied to Heart Attacks, Dana-Farber Cancer Institute Study

Prostate cancer drugs from AstraZeneca Plc, Watson Pharmaceuticals Inc. and others don’t increase the risk of heart attacks in men with no history of the disease, a study said, contradicting earlier reports.

MORE ON THIS TOPIC